SENTRIP
LIVE

Serial Number

90830324

Owner

C.L PHARM.CO., LTD.

Attorney

Yoon S. Ham

Filing Date

Jul 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SENTRIP Trademark

Serial Number: 90830324 • Registration: 7129375

SENTRIP is a trademark filed by C.L PHARM.CO., LTD. on July 15, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

C.L PHARM.CO., LTD. (4 trademarks)

1605, Seoul Forest IT Castle,
Seoul 04788 , KR

Entity Type: 03

Trademark Details

Filing Date

July 15, 2021

Registration Date

August 8, 2023

Published for Opposition

May 23, 2023

Goods & Services

Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals for the treatment of premature ejaculation; Pharmaceutical preparations for the prevention of sexual neuropathy; Pharmaceuticals for the treatment of sexual neuropathy; Pharmaceutical preparations for urogenital organs; Hormone preparations for medical purposes; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents for epidermis; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents for treating physically caused lesions; Cardiovascular pharmaceutical preparations; Nutritional supplements, namely, tonics and alternatives, namely, herbal tonics, nutritional tonics, and medicinal drinks for medical use; Chemotherapeutics; Chemical contraceptives; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical products for the treatment of bacterial infections; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical preparations and substances for use in gynecology; Pharmaceutical preparations for the treatment of heart rhythm disorders; Psychotropics; Pharmaceutical preparations for the treatment of musculoskeletal disorders; Pharmaceuticals for the treatment of sexual disorder

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 8, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 8, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 23, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 23, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 3, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 13, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 13, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 13, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 13, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2023 CRFA
ASSIGNED TO LIE
Mar 4, 2023 ALIE
ASSIGNED TO LIE
Mar 4, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2022 TROA
ASSIGNED TO EXAMINER
Aug 30, 2022 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 28, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 28, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 28, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 5, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2021 NWOS
NEW APPLICATION ENTERED
Jul 19, 2021 NWAP